More Stories

Informist, Wednesday, Feb. 11, 2026

 

By Diksha Tripathy    

 

MUMBAI – Fortis Healthcare Ltd. is expected to post healthy year-on-year double-digit growth in its consolidated net profit and revenue in the December quarter due to improved operating leverage, led by a ramp-up of the company's new units in Jalandhar, Manesar, and Greater Noida, brokerages said.

 

For the December quarter, Fortis Healthcare's consolidated net profit is expected to grow nearly 16% on year to INR 2.60 billion, according to the average of estimates from six brokerages. Sequentially, the net profit is expected to decline by nearly 13%. The highest estimate for the company's net profit is INR 2.72 billion from ICICI Securities Ltd. and the lowest is INR 2.54 billion from SMIFS Ltd.

 

The company's revenue is expected to be INR 22.66 billion in the December quarter, up nearly 18% on year, according to the estimates. Sequentially, revenue is expected to decline by nearly 3%. The highest estimate for the company's net sales is INR 23.01 billion from ICICI Securities, and the lowest is INR 22.45 billion from JM Financial Institutional Securities Pvt. Ltd.

 

Fortis Healthcare's earnings before interest, tax, depreciation, and amortisation are expected to be INR 5.08 billion for the December quarter, according to the average of estimates. The highest estimate for the EBITDA is INR 5.21 billion from Nuvama Wealth Management Ltd. and the lowest is INR 4.83 billion from JM Financial.

 

The December quarter is relatively weaker than the other quarters for hospitals due to a slowdown in elective procedures led by the festival season. This affects the key metrics of the business, such as bed occupancies and volume, according to brokerages.

 

For the September quarter, Fortis Healthcare reported a consolidated net profit of INR 3.22 billion, up 82% on year, on revenues of INR 23.31 billion, up 17% on year.

 

Of the seven brokerage reports on the company available with Informist, five have a 'buy' or equivalent recommendation with an average price of INR 1,087. This is over 18% higher than the current market price. The remaining two have a 'hold' recommendation on the stock with an average target price of INR 990.

 

The company will announce its December quarter earnings Friday.

 

Wednesday, shares of the company closed at INR 918.85 on the National Stock Exchange, up 3.0% from the previous close. The stock is down over 5% since the company announced its September quarter earnings.

 

The following are the December quarter earnings estimates for Fortis Healthcare from six brokerages in descending order of the estimate of net profit in INR billion:

 

Brokerages	Net Sales	Net Profit	EBITDA
ICICI Securities Ltd.	23.01	2.72	5.20
Nuvama Wealth Management Ltd.	22.59	2.67	5.21
JM Financial Institutional Securities Pvt. Ltd.	22.45	2.56	4.83
Prabhudas Lilladher Pvt. Ltd.	22.48	2.55	5.00
Elara Securities (India) Pvt. Ltd.	22.84	2.55	5.15
SMIFS Ltd.­­	22.57	2.54	5.10
Average	22.66	2.60	5.08

 

 

End

 

Edited by Saji George Titus

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.